Cancer genome scanning in plasma: detection of tumor-associated copy number aberrations, single-nucleotide variants, and tumoral heterogeneity by massively parallel sequencing.
about
Liquid biopsy in patients with pancreatic cancer: Circulating tumor cells and cell-free nucleic acidsLiquid Biopsy of Hepatocellular Carcinoma: Circulating Tumor-Derived BiomarkersCirculating tumor DNA: a promising biomarker in the liquid biopsy of cancerCirculating tumor DNA in hepatocellular carcinoma: trends and challengesCell-free circulating tumor DNA in cancerCurrent Challenges in Glioblastoma: Intratumour Heterogeneity, Residual Disease, and Models to Predict Disease Recurrence"Liquid biopsy"-ctDNA detection with great potential and challengesBiological features and biomarkers in hepatocellular carcinomaCirculating RNAs as new biomarkers for detecting pancreatic cancerSystemic treatment for inoperable pancreatic adenocarcinoma: review and updateRole of rebiopsy in relapsed non-small cell lung cancer for directing oncology treatmentsLiquid biopsies: genotyping circulating tumor DNACirculating tumor DNA as a liquid biopsy target for detection of pancreatic cancerBlood-based Tumor Markers in Lung CancerBlood-based analyses of cancer: circulating tumor cells and circulating tumor DNAEGFR-TKI resistance in NSCLC patients: mechanisms and strategiesNon-invasive analysis of acquired resistance to cancer therapy by sequencing of plasma DNAPlasma DNA tissue mapping by genome-wide methylation sequencing for noninvasive prenatal, cancer, and transplantation assessmentsAn ultrasensitive method for quantitating circulating tumor DNA with broad patient coverage.Circulating Tumor DNA as Biomarkers for Cancer Detection.Novel Algorithms for Improved Sensitivity in Non-Invasive Prenatal Testing.Size-based molecular diagnostics using plasma DNA for noninvasive prenatal testing.Assessment of circulating copy number variant detection for cancer screening.Evaluation of exome sequencing to estimate tumor burden in plasma.Establishment of tumor-specific copy number alterations from plasma DNA of patients with cancer.Liquid biopsy: monitoring cancer-genetics in the blood.Tumour heterogeneity in the clinic.Noninvasive detection of cancer-associated genome-wide hypomethylation and copy number aberrations by plasma DNA bisulfite sequencingMultifocal clonal evolution characterized using circulating tumour DNA in a case of metastatic breast cancerNoninvasive prenatal molecular karyotyping from maternal plasma.Plasma DNA aberrations in systemic lupus erythematosus revealed by genomic and methylomic sequencing.A mixture model for expression deconvolution from RNA-seq in heterogeneous tissues.The dynamic range of circulating tumor DNA in metastatic breast cancerGenome aberrations in canine mammary carcinomas and their detection in cell-free plasma DNA.Changes in colorectal carcinoma genomes under anti-EGFR therapy identified by whole-genome plasma DNA sequencing.Lengthening and shortening of plasma DNA in hepatocellular carcinoma patients.Detection of tumor ALK status in neuroblastoma patients using peripheral blood.Plasma genetic and genomic abnormalities predict treatment response and clinical outcome in advanced prostate cancerHigh-resolution characterization of sequence signatures due to non-random cleavage of cell-free DNA.Exome Sequencing of Cell-Free DNA from Metastatic Cancer Patients Identifies Clinically Actionable Mutations Distinct from Primary Disease
P2860
Q26739062-C49EE621-2851-4A84-BE38-E76A2B271338Q26741204-C83DC9FE-4E41-44C0-9576-B4DF91AA421CQ26746010-1A8033BC-3DBB-41C6-A2E0-0CC6548E6CFCQ26749417-B859C828-E812-4574-AFF6-FE0E92704D65Q26750899-1649D22A-6161-46B8-BDC2-1529E4A704A6Q26774502-DCC5B6F0-543C-4C75-82A0-835FCAB30CD6Q26779222-0CC08B59-917A-46DD-A5CD-C268164AC3C0Q26799462-8A993528-A703-4993-96F1-9A23C123E72BQ26801191-80796984-C497-476A-8CD0-8D0034593FF9Q26830913-08611F3D-3893-4F7B-82AC-0460C70A82ADQ26852206-35AA3A9C-0AA1-4531-A538-EDD53EC94C9EQ27010159-94FB9CFD-2201-4F8D-A8E3-EF806D11D0B3Q28069755-F0916064-EFDB-4ED3-9257-5C5EA74A8165Q28072736-CC5BEF12-2EC5-42FD-B1F4-7524C5A2C711Q28239638-66B8368B-B7E1-47B5-826E-ED2D1D669318Q28394310-BA396165-E527-4E4F-8D60-60DFAC665750Q29620083-6A5FA1A8-777E-4C7C-B174-4AD14F3673A0Q30667824-6764687F-1045-4E48-9DC0-58F531E979B2Q33590850-582FCC3B-EFE2-4DD9-A1E6-F0F1DED2294EQ33632125-3565AB75-A0A6-494E-A0EB-7FE4EF1F4807Q33686861-A6EAF130-0966-4A8B-8D35-B4A5027F5408Q33767643-6EC7C2B6-5924-4ED6-B6BE-E7173F87ED21Q33884196-A2B0D570-94DA-45BC-A979-8BFF2B48D6E6Q34061593-9FCBDE6C-A68D-4BDC-9B28-E673B3536853Q34322575-1371CA28-E0B4-4D8E-A94F-08EADF303735Q34356149-26016851-6A81-4A76-875D-60CFB7781577Q34372080-0FC76453-B1EE-4C39-B34C-9EA1D1A5A34CQ34382581-438F1D92-6C3A-434A-8B76-629761F2B91AQ34500359-009E86A5-E985-43E9-B6EC-586F4B8D41CAQ34683906-6F129EA0-4E13-4C6F-A005-B0924DBFEA69Q34709085-46A8DA08-5CEF-414F-ABBC-E12129AC4270Q34756607-D67DC63D-7AB7-45BE-AB8A-F399E62C8C7BQ35000808-483D8A28-6AB6-483C-B935-B905F0EBEA31Q35010017-EE1D1CEF-18FC-42B4-8B68-E8EB2744CBE4Q35133788-28C561B6-6E29-42D8-B825-9AE52FAB349CQ35212779-0B68CFE7-4219-48AF-BF84-EF6AAE4366B9Q35469393-808E73EF-E126-41F9-A0F0-876C794EFECAQ35615320-FC3BF16A-9B13-4083-B0F2-56F0B0181D34Q35665317-07BA64E0-43C4-4A2D-B303-1F00A4D377CBQ35758472-5FFAED49-342A-4740-A532-956339D3DC3E
P2860
Cancer genome scanning in plasma: detection of tumor-associated copy number aberrations, single-nucleotide variants, and tumoral heterogeneity by massively parallel sequencing.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
2012年學術文章
@zh-hant
name
Cancer genome scanning in plas ...... massively parallel sequencing.
@en
Cancer genome scanning in plas ...... massively parallel sequencing.
@nl
type
label
Cancer genome scanning in plas ...... massively parallel sequencing.
@en
Cancer genome scanning in plas ...... massively parallel sequencing.
@nl
prefLabel
Cancer genome scanning in plas ...... massively parallel sequencing.
@en
Cancer genome scanning in plas ...... massively parallel sequencing.
@nl
P2093
P1433
P1476
Cancer genome scanning in plas ...... massively parallel sequencing.
@en
P2093
Anthony T C Chan
Gary J W Liao
K C Allen Chan
Peiyong Jiang
Rossa W K Chiu
Shing Shun N Siu
Stephen L Chan
Wing C Chan
P304
P356
10.1373/CLINCHEM.2012.196014
P407
P577
2012-10-11T00:00:00Z